Abstract
Antipsychotics are commonly used for managing behavioral and psychological symptoms of dementia among elderly patients with dementia receiving antidementia drugs (ADDs). However, the use of antipsychotics among these patients has not been investigated since 3 ADDs were approved in 2011 in Japan. We conducted a descriptive study using pharmacy prescription data and identified patients aged ≥65 years who were newly prescribed donepezil, memantine, rivastigmine, and galantamine between January 1, 2012, and September 30, 2014. We determined the proportion of antipsychotic prescription and the factors affecting antipsychotic prescription using multivariable Cox proportional hazard models. Of 13 876 patients, 1705 were memantine users, and the proportion of antipsychotic prescription among them was the highest (11.1%). Adjusted hazard ratios for donepezil, rivastigmine, and galantamine were 0.66, 0.56, and 0.66, respectively, relative to that for memantine. Compared to other ADD users, new memantine users were most likely to be prescribed antipsychotics.
References
Apr 28, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Eric Wooltorton
Mar 19, 2005·Dementia and Geriatric Cognitive Disorders·Maristella PiccininniDomenico Inzitari
Oct 20, 2005·JAMA : the Journal of the American Medical Association·Lon S SchneiderPhilip Insel
Dec 2, 2005·The New England Journal of Medicine·Philip S WangM Alan Brookhart
Jul 4, 2007·International Journal of Geriatric Psychiatry·Martin SteinbergUNKNOWN Cache County Investigators
Dec 7, 2007·International Journal of Geriatric Psychiatry·S GauthierJ Cummings
Feb 26, 2008·The Journal of Clinical Psychiatry·Gordon K WilcockHenrik Loft
Dec 14, 2011·PloS One·Hisashi UrushiharaKoji Kawakami
May 24, 2012·Dementia and Geriatric Cognitive Disorders Extra·Juha PuustinenSirkka-Liisa Kivelä
Jun 21, 2012·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Chiaki IkejimaTakashi Asada
Jan 10, 2013·BMJ Open·Carlos MartinezStephan Rietbrock
Apr 4, 2013·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Jean LachaineSébastien Bineau
Oct 25, 2014·Age and Ageing·Jennifer Ngo, Jayna M Holroyd-Leduc
Apr 24, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Heii AraiUNKNOWN J-CATIA Study Group
Apr 27, 2016·International Journal of Geriatric Psychiatry·Kristina JohnellPeter Salmi
Nov 30, 2016·Neurology and Therapy·Kimiko KadoharaKoji Kawakami
Mar 8, 2017·Pharmacoepidemiology and Drug Safety·Kenji KochiKoji Kawakami
May 17, 2017·Psychopharmacology·Taro KishiNakao Iwata